北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (1): 83-89. doi: 10.19723/j.issn.1671-167X.2020.01.013

• 论著 • 上一篇    下一篇

腮腺CT影像报告与数据系统的初步研究

李玉冰1,孙丽莎2,孙志鹏1,(),谢晓艳1,张建运3,张祖燕1,赵燕平1,马绪臣1   

  1. 1. 北京大学口腔医学院·口腔医院, 医学影像科, 北京 100081
    2. 北京大学口腔医学院·口腔医院,中心实验室, 北京 100081
    3. 北京大学口腔医学院·口腔医院,口腔病理科 国家口腔疾病临床医学研究中心 口腔数字化医疗技术和材料国家工程实验室 口腔数字医学北京市重点实验室, 北京 100081
  • 收稿日期:2019-10-10 出版日期:2020-02-18 发布日期:2020-02-20
  • 通讯作者: 孙志鹏 E-mail:sunzhipeng@bjmu.edu.cn

Parotid CT imaging reporting and data system: A preliminary study

Yu-bing LI1,Li-sha SUN2,Zhi-peng SUN1,(),Xiao-yan XIE1,Jian-yun ZHANG3,Zu-yan ZHANG1,Yan-ping ZHAO1,Xu-chen MA1   

  1. 1. Department of Oral Pathology, Peking University School and Hospital of Stomatology & Department of Oral and Maxillofacial Radiology, Beijing 100081, China
    2. Department of Oral Pathology, Peking University School and Hospital of Stomatology & Central Laboratory, Beijing 100081, China
    3. Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2019-10-10 Online:2020-02-18 Published:2020-02-20
  • Contact: Zhi-peng SUN E-mail:sunzhipeng@bjmu.edu.cn

摘要:

目的:初步建立腮腺CT影像报告与数据系统(Parotid Imaging Reporting and Data System,PI-RADS),并探讨其临床应用价值。方法:纳入2013年1月至2016年12月间因腮腺肿物就诊于北京大学口腔医院并进行手术治疗的病例,回顾性评估所有病例的影像资料,获取相关影像特征,评估肿瘤恶性风险概率,并分为6个等级(1级,正常腮腺; 2级,基本确定为良性病变或肿瘤; 3级,无明确恶性病变证据但不能确定为良性病变; 4级,怀疑为恶性肿瘤病变但证据不充分; 5级,恶性肿瘤影像征象较充分; 6级,有恶性肿瘤病理学证据)。结果:共纳入腮腺肿物病例897例次,其中良性病变905例次、恶性肿瘤98例次,影像诊断为2级、3级、4级和5级的病变中,恶性肿瘤的构成比分别为0.4%、5.7%、35.5%和96.7%,随PI-RADS分级呈逐渐增高趋势(Z=-15.579,P<0.001)。相邻等级[2级与3级(χ 2=12.048,P=0.001)、3级与4级(χ 2=75.231,P<0.001)、4级与5级(χ 2=32.266,P<0.001)]之间的恶性构成比差异有统计学意义。Cohen’s Kappa检验表明两位研究者分级诊断具有中度一致性(κ=0.614,P<0.001,95%CI: 0.569~0.695)。结论:应用影像诊断分级方法对腮腺肿瘤性疾病的诊断和临床治疗有一定的帮助。

关键词: 腮腺肿瘤, 体层摄影术, X线计算机, 诊断, 鉴别, 治疗

Abstract:

Objective: To establish a Parotid Imaging Reporting and Data System (PI-RADS) for CT diagnosis of the parotid gland neoplasms and to investigate the clinical applicable value and feasibility of PI-RADS. Methods: Patients who had been diagnosed with primary parotid gland neoplasms and had received surgical treatments in Peking University School and Hospital of Stomatology during the period of January 2013 to December 2016 were included in this study. The diagnoses were confirmed by the postoperative pathological examinations in all the patients. The CT imaging data of all patients were retrospectively reviewed and analyzed by two readers in consensus. Imaging characteristics related to the parotid neoplasms were extracted and quantified. Based on comprehensive analysis of the imaging characteristics, the probabilities of the benign and malignant neoplasms were evaluated and classified into six grades, PI-RADS 1-6 (PI-RADS 1: normal parotid gland; PI-RADS 2: confidently benign lesions; PI-RADS 3: probably benign lesions without confirmed evidence of malignancy; PI-RADS 4: suspected malignancy without sufficient evidence of malignancy; PI-RADS 5: confidently malignant lesions; PI-RADS 6: lesions with confirmed pathological evidence of malignancy). Results: A total of 897 patients with 1 003 parotid lesions were included. The lesions included 905 benign and 98 malignant lesions. The proportions of the malignancies in PI-RADS 2, PI-RADS 3, PI-RADS 4 and PI-RADS 5 according to the two readers in consensus were 0.4%, 5.7%, 35.5% and 96.7% respectively. The overall Cohen’s Kappa test showed medium consistency between the two independent researchers (κ=0.614, P<0.001, 95%CI: 0.569-0.695). Pearson Chi-square test showed that the proportions of malignancies increased with the diagnostic PI-RADS grades (Cochran-Armitage trend test, Z=-15.579, P<0.001). The results of Pearson Chi-square tests showed significant differences between the grades [PI-RADS 2 and 3 (χ 2=12.048, P=0.001); PI-RADS 3 and 4 (χ 2=75.231, P<0.001); PI-RADS 4 and 5 (χ 2=32.266, P<0.001)]. Conclusion: PI-RADS can be used to evaluate the risk of malignancy and will be helpful to improve the imaging diagnosis and clinical treatment of paro-tid gland neoplasms.

Key words: Parotid neoplasms, Tomography, X-ray computed, Diagnosis, differential, Therapy

中图分类号: 

  • R739.87

表1

腮腺肿物PI-RADS诊断结果与影像学征象"

Items PI-RADS 2 PI-RADS 3 PI-RADS 3b PI-RADS 4 PI-RADS 5 PI-RADS 6 Benign Malignancy
Size
Small (<2.0 cm) 30 82 7 7 2 0 118 10
Medium (2.0-3.0 cm) 158 453 4 49 14 1 624 55
Large (>3.0 cm) 56 102 1 20 14 3 163 33
Single/multiple
Single on one side 139 584 0 62 19 3 730 77
Multiple on one side 33 25 5 11 9 1 66 18
Multiple on two sides 72 28 7 3 2 0 109 3
Boundary
Absolutely clear 153 153 0 3 0 0 309 0
Majorly clear 68 261 2 21 4 0 345 11
Partially ill-defined 17 182 1 26 3 1 210 20
Majorly ill-defined 6 38 7 18 8 3 37 43
Ill-defined 0 3 2 8 15 0 4 24
Shape
Round 54 269 5 21 7 0 334 22
Oval 154 162 3 13 3 0 322 13
Scalloped 31 182 2 27 6 2 222 28
Irregular 5 24 2 15 14 2 27 35
Dominant density on plain CT
Fat 7 1 0 0 0 0 8 0
Liquid 30 59 0 4 12 0 91 2
Soft-tissue (partial fluid) 66 239 1 36 18 3 311 46
Soft-tissue 141 338 11 36 0 1 495 50
Enhancement degree on first enhanced phase
No significant 25 42 0 3 0 0 68 2
Slightly 10 122 0 12 4 0 140 8
Medium 29 203 5 32 13 1 236 47
Obvious 89 114 7 21 11 3 217 28
Significant 67 53 0 5 1 0 119 7
Enhancement pattern
Gradual 20 294 5 30 11 1 333 28
Fast in-out 124 128 1 23 7 2 254 31
Basically no enhancement 4 4 0 2 1 0 8 3
Gradual in-out 9 51 2 10 2 0 61 13
Enhancement distribution
Membrane enhancement 5 34 0 7 0 0 40 6
Even 152 182 12 24 15 1 346 36
Uneven to even 17 198 0 21 5 1 223 20
Uneven 14 84 0 17 8 2 99 26
No enhancement 32 36 0 4 0 0 72 0
Calcification
No 239 602 12 59 26 4 861 81
Small granular or capsule 5 31 0 10 1 0 38 9
Large irregular 0 4 0 7 3 0 6 8
Cystic percentage
0 177 488 12 49 26 2 683 71
≤25% 19 53 0 10 2 2 72 14
>25%, ≤50% 7 17 0 6 2 0 23 9
>50%, ≤75% 5 33 0 5 0 0 40 3
>75% 36 46 0 6 0 0 87 1
Adjacent structure destruction
No 237 609 7 64 16 3 867 69
Move 5 19 0 5 0 0 26 3
Poor boundary 2 8 5 6 9 0 12 18
Significant 0 1 0 1 5 1 0 8

图1

PI-RADS 2级(A)、3级(B)、4级(C)、5级(D)诊断的典型病例"

表2

腮腺CT影像报告与数据系统的诊断标准"

PI-RADS Criteria
1: Normal parotid gland There are definitely no masses in the parotid gland
2: More likely benign (1) Multiple bilateral or unilateral masses presented regular arc border and oval contour with enhancement and without enlarged or necrotic lymph nodes around the parotid gland and neck; (2) A single tumor may also be considered if it is typical (e.g. oval, with obvious and uniform enhancement in the first enhancement phase, with smooth clear border or a low-density fat envelope)
3: Indeterminate (1) Single, round, no enhancement or uniform enhancement, most of the boun-dary clear, for example majorly clear or partially ill-defined; (2) Granular with uneven enhancement but definite boundary; (3) Multiple without enhancement, and without enlarged or necrotic lymph nodes around the parotid gland and neck; (4) Small tumors, that means, all tumors diameter less than 1 cm are included, regardless of their enhancement features
3b: Inflammation including Sjögren
syndrome and IgG4
In multiple gland, lesions are diffuse, with enhancement, without necrotic lymph nodes around the neck
4: Probably malignant (1) Single lesion, the shape is slightly irregular, part of the boundary is indistinctly (the boun-dary marked 3 or 4) or the membrane enhancement with villous edges; (2) The enhancement type is medium enhancement even slightly enhancement, solid lesion with little or without cystic degeneration; (3) Soft tissue density or with partial fluid especially with calcification, a small amount of unilateral diffuse; (4) Have large masses of irregular calcification with swelling lymph nodes but without necrosis lymph nodes
5: Highly suggestive malignancy (1) Necrotic lymph nodes are seen in the neck; (2) The boundary is unclear, the shape is irregular; (3) The border of the surrounding muscles, bones or fat tissues are not clear, which means destruction
6: Already had malignant diagnosis Had pathological result to pronounced it is a malignant neoplasm
7: Unsatisfied illustration on CT The density of neoplasm and the parotid is too nearly to find out what the neoplasm is really like. But couldn’t exclude that a neoplasm may exist

表3

腮腺肿物病理诊断与PI-RADS诊断结果的相关性"

Items PI-RADS 2 PI-RADS 3 PI-RADS 3b PI-RADS 4 PI-RADS 5 PI-RADS 6 PI-RADS total
Warthin tumor 176 72 0 5 0 0 253
Pleomorphic adenoma 4 367 0 23 1 0 395
Basal cell adenoma 11 81 0 2 0 0 94
Myoepithelioma 0 3 0 0 0 0 3
Oncocytoma 4 4 0 0 0 0 8
Cystadenoma 0 6 0 0 0 0 6
Keratocystoma 0 0 0 1 0 0 1
Cyst 28 14 0 0 0 0 42
Lipoma 4 1 0 0 0 0 5
Schwannoma 0 9 0 0 0 0 9
Vascular malformation 2 9 0 2 0 0 13
Eosinophilic lymphogranuloma 0 1 2 0 0 0 3
Inflammation 13 31 9 12 0 0 65
Calcified epithelioma 1 1 0 0 0 0 2
Non-sebaceous lymphoadenoma 0 0 0 1 0 0 1
Lymphoepithelial lesions 0 0 0 3 0 0 3
Nodular fasciitis 0 1 0 0 0 0 1
Myofibromatosis 0 1 0 0 0 0 1
Mucoepidermoid carcinoma 1 6 0 6 6 1 20
Adenocarcinoma, NOS 0 2 0 3 4 0 9
Acinic cell carcinoma 0 13 0 2 0 0 15
Salivary duct carcinoma 0 0 0 1 3 0 4
Adenoid cystic carcinoma 0 4 0 0 3 0 7
Polymorphous adenocarcinoma 0 3 0 5 1 0 9
Uncertainty adenocarcinoma 0 0 1 2 5 0 8
Epithelial-myoepithelial carcinoma 0 1 0 0 0 0 1
Clear cell carcinoma 0 0 0 0 1 0 1
Oncocytic carcinoma 0 0 0 2 0 0 2
Sarcoma 0 1 0 0 0 1 2
Lymphoepithelial carcinoma 0 1 0 2 2 2 7
Malignant lymphoma 0 4 0 3 4 0 11
Malignant melanoma 0 0 0 1 0 0 1
Metastatic solitary fibroma 0 1 0 0 0 0 1
Total 244 637 12 76 30 4 1 003
[1] 张震康, 俞光岩 . 口腔颌面外科学[M]. 2版. 北京: 北京大学医学出版社, 2013.
[2] Abdullah A, Rivas FF, Srinivasan A . Imaging of the salivary glands[J]. Semin Roentgenol, 2013,48(1):65-74.
[3] 俞光岩, 高岩, 孙勇刚 . 口腔颌面部肿瘤[M]. 北京: 人民卫生出版社, 2002.
[4] Seethala RR, Stenman G . Update from the 4th edition of the World Health Organization classification of head and neck tumours: Tumors of the salivary gland[J]. Head Neck Pathol, 2017,11(1):55-67.
[5] White SC, Pharoah MJ . Oral radiology principles and interpretation[M]. 3rd ed. St. Louis, Missouri: Mosby Elsevier, 2014.
[6] 马绪臣 . 口腔颌面医学影像学[M]. 北京: 北京大学医学出版社, 2014.
[7] 马绪臣, 李铁军 . 口腔颌面部疾病CT诊断与鉴别诊断[M]. 北京: 北京大学医学出版社, 2019.
[8] Horvath E, Majlis S, Rossi R , et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical ma-nagement[J]. J Clin Endocrinol Metab, 2009,94(5):1748-1751.
[9] Barentsz JO, Richenberg J, Clements R , et al. ESUR prostate MR guidelines 2012[J]. Eur Radiol, 2012,22(4):746-757.
[10] Abdel Razek AA, Ashmalla GA, Gaballa G , et al. Pilot study of ultrasound parotid imaging reporting and data system (PIRADS): Inter-observer agreement[J]. Eur J Radiol, 2015,84(12):2533-2538.
[11] 马大权, 俞光岩 . 唾液腺病学[M]. 2版. 北京: 人民卫生出版社, 2014.
[12] Kim H, Kim SY, Kim YJ , et al. Correlation between computed tomography imaging and histopathology in pleomorphic adenoma of parotid gland[J]. Auris Nasus Larynx, 2018,45(4):783-790.
[13] Ito FA, Jorge J, Vargas PA , et al. Histopathological findings of pleomorphic adenomas of the salivary glands[J]. Med Oral Patol Oral Cir Bucal, 2009,14(2):E57-61.
[14] 黄敏娴, 马大权, 俞光岩 , 等. 复发性涎腺多形性腺瘤的临床与病理分析[J]. 现代口腔医学杂志, 2008,22(1):1-4.
[1] 李熠,尉华杰,邱立新. 种植体折裂的临床分型与临床治疗方案[J]. 北京大学学报(医学版), 2022, 54(1): 126-133.
[2] 李伟浩,李伟,张学民,李清乐,焦洋,张韬,蒋京军,张小明. 去分支杂交手术和传统手术治疗胸腹主动脉瘤的结果比较[J]. 北京大学学报(医学版), 2022, 54(1): 177-181.
[3] 孟广艳,张筠肖,张渝昕,刘燕鹰. IgG4相关性疾病中枢神经系统受累的临床特点分析[J]. 北京大学学报(医学版), 2021, 53(6): 1043-1048.
[4] 张学武. 痛风关节炎治疗中几个备受关注的问题[J]. 北京大学学报(医学版), 2021, 53(6): 1017-1019.
[5] 翟莉,邱楠,宋惠. 多中心网状组织细胞增生症1例[J]. 北京大学学报(医学版), 2021, 53(6): 1183-1187.
[6] 王飞,朱翔,贺蓓,朱红,沈宁. 自发缓解的滤泡性细支气管炎伴非特异性间质性肺炎1例报道并文献复习[J]. 北京大学学报(医学版), 2021, 53(6): 1196-1200.
[7] 杨刚,胡文杰,曹洁,柳登高. 牙周健康的上颌前牙唇侧嵴顶上牙龈的三维形态分析[J]. 北京大学学报(医学版), 2021, 53(5): 990-994.
[8] 朱正达,高岩,何汶秀,方鑫,刘洋,魏攀,闫志敏,华红. 红色诺卡氏菌细胞壁骨架治疗糜烂型口腔扁平苔藓的疗效及安全性[J]. 北京大学学报(医学版), 2021, 53(5): 964-969.
[9] 洪鹏,田晓军,赵小钰,杨飞龙,刘茁,陆敏,赵磊,马潞林. 肾移植术后双侧乳头状肾癌1例[J]. 北京大学学报(医学版), 2021, 53(4): 811-813.
[10] 李新飞, 彭意吉, 余霄腾, 熊盛炜, 程嗣达, 丁光璞, 杨昆霖, 唐琦, 米悦, 吴静云, 张鹏, 谢家馨, 郝瀚, 王鹤, 邱建星, 杨建, 李学松, 周利群. 肾部分切除术前CT三维可视化评估标准的初步探究[J]. 北京大学学报(医学版), 2021, 53(3): 613-622.
[11] 邱敏,费月阳,邓绍晖,刘承,卢剑,何为,陆敏,田晓军,张树栋,马潞林. 后肾腺瘤的诊治经验及文献回顾[J]. 北京大学学报(医学版), 2021, 53(2): 417-419.
[12] 孟圆,张丽琪,赵雅宁,柳登高,张祖燕,高岩. 67例上颌根尖周囊肿的三维影像特点分析[J]. 北京大学学报(医学版), 2021, 53(2): 396-401.
[13] 王昱,邓雪蓉,季兰岚,张晓慧,耿研,张卓莉. 超声检测痛风患者肌腱受累的危险因素和诊断价值[J]. 北京大学学报(医学版), 2021, 53(1): 143-149.
[14] 周境,刘怡. 不同垂直骨面型骨性Ⅱ类青少年女性颞下颌关节锥形束CT测量分析[J]. 北京大学学报(医学版), 2021, 53(1): 109-119.
[15] 高璐,谷岩. 中国人群腭中缝形态特点分期与Demirjian牙龄的相关性[J]. 北京大学学报(医学版), 2021, 53(1): 133-138.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[7] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[8] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[9] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .
[10] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .